期刊文献+

复方奥硝唑甲磺酸培氟沙星缓释牙栓的研制及质量控制 被引量:3

Preparation and Quality Control of Compound Ornidazole and Pefloxacin Mesylate Sustained-release Periodontal Suppository.
暂未订购
导出
摘要 目的:制备复方奥硝唑甲磺酸培氟沙星缓释牙栓,并建立质量控制标准。方法:以奥硝唑甲磺酸培氟沙星为主药,羟丙甲纤维素(HPMC)、乙基纤维素(EC)等为牙栓基质,按冷压法制备复方缓释牙栓,并采用紫外分光光度法测定牙栓中药物含量。结果:所制牙栓为扁梭形淡黄色小体,有良好的弹性韧性;两药回收率均在95%-100%之间,标示量均在90%-110%之间。结论:该牙栓制备工艺简单,符合2005年版《中国药典》对栓剂的规定。质量控制方法准确。为深入研究奠定了基础。 Objective: To prepare compound omidazole and pefloxacin mesylate sustained -release periodontal suppository and establish the quality standard. Methods: The suppository wasprepared with omidazole and pefloxacin mesilate as main ingredient,and hypromellose and ethylcellulose as slow- release base material. The quality standard was established by DU. Results: The periodontal suppository was yellow, flat fusiform body, with satisfactory elasticity and ductility. The recovery rates of boty medicine were between 95% - 100%, and the marked content was between 90% - 110%. Conclusion: The preparation technique is simple, convenient and corresponds to the regular of "Chinese Pharmacopeia" on suppository. Quality control is accurate and precise in, which establishs the foundation for further research.
出处 《口腔医学研究》 CAS CSCD 2007年第1期10-13,共4页 Journal of Oral Science Research
关键词 奥硝唑 甲磺酸培氟沙星 缓释 牙栓 Omidazole Pefloxacin mesylate Sustained - release Periodontal suppository
  • 相关文献

参考文献5

  • 1Tanner A,Maiden MF,Macuch PJ.Microbiota of health,gingivitis,and initial periodontitis[J].J Clin Periodontol,1998,25(2):85-98
  • 2段延华,刘鲁川,蒋艳,李楠,张莉,熊辉,孟德胜.奥硝唑和培氟沙星不同配伍对牙周病原菌体外抗菌作用[J].口腔医学研究,2006,22(2):162-165. 被引量:8
  • 3Goodson JM,Haffajee A,Socransky SS.Periodontal therapy by local delivery of tetracycline[J].J Clin Periodonto,1979,6(2):83-92
  • 4Verhoeven E,Vervaet C,Remon JP,et al.Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion:in vitro and in vivo evaluation[J].Eur J Pharm Biopharm,2006,3(3)
  • 5Dahl TC,Calderwood T,Bormeth A,et al.Influence of physicochemical properties of hydroxypropylmethylcellulose on naproxen release from sustained release matrix tablets[J].J Control Release,1990,14(05):1-10

二级参考文献10

  • 1刘学聪,边百川,张玉.奥硝唑糊剂治疗牙周炎的近期疗效观察[J].现代中西医结合杂志,2004,13(15):2019-2019. 被引量:12
  • 2李从荣,金正江,詹,丁俊清,李艳,彭少华.奥硝唑治疗口腔厌氧菌感染的临床与实验研究[J].中华医院感染学杂志,2004,14(3):325-327. 被引量:40
  • 3Cennet Celik.In vitro activities of tinidazole and metronidazole against clostridium diffieile,prevotellabivia and bacteroides fragilis[J].Anaerobe,2005,4(17):101-103
  • 4周学东,肖晓蓉.口腔微生物学[M].四川大学出版社,2001,4(15):390-407
  • 5Socransky S,Haffajee A.Evidence of aetiology:a historical perspective[J].Periodontol,2000,1994(5):7-10
  • 6Zambon JJ.Periodontal diseases:microbial factors[J].An Periodontol,1996,1(12):879-883
  • 7Tyrrell KL.In vitro activity of oritavancin (LY333328),vancomycin,clindamycin,and metronidazole against Clostridium perfringens,Propionibacterium acnes,and anaerobic Gram-positive cocci[J].Anaerobe,2005,11(2):93-95
  • 8Kamma JJ,Nakou M,Mitsis FJ.The clinical and microbiological effects of systemic ornidazole in sites with and without subgingival debridement in early-onset periodontitis patients[J].Periodonto,2000,71(12):1 862-1 865
  • 9Sydney M.Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota[J].Anaerobe,2004,10(5):255-259
  • 10于守汎.培氟沙星在目前抗菌疗法中的地位[J].国外医药(抗生素分册),2002,23(4):179-181. 被引量:7

共引文献7

同被引文献33

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部